UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 2, 2004
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
|
Delaware |
1-3433 |
38-1285128 |
2030 Dow Center, Midland, Michigan 48674
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(989) 636-1000
Not applicable
(Former name or former address, if changed since last report.)
Item 5. Other Events
The Dow Chemical Company issued a press release on August 2, 2004, the text of which is contained in the Exhibit filed herein.
Item 7. Financial Statements and Exhibits
The following exhibit is filed as a part of this report:
Exhibit No. 99
News Release - Andrew N. Liveris to Become CEO of The Dow Chemical Company; William Stavropoulos Will Continue as Chairman
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: August 2, 2004 THE DOW CHEMICAL COMPANY
By: /S/ FRANK H. BROD
Name: Frank H. Brod
Title: Vice President and Controller
EXHIBIT INDEX
EXHIBIT NO. 99 DESCRIPTION
Andrew N. Liveris to Become CEO of The Dow Chemical Company; William Stavropoulos Will Continue as Chairman